IL165988A0 - Process for the preparation of fibrinogen - Google Patents

Process for the preparation of fibrinogen

Info

Publication number: IL165988A0
Authority: IL; Israel
Prior art keywords: fibrinogen; preparation; purification; processes; relates
Prior art date: 2002-07-10

Application number

IL16598804A

Other languages

English (en)

Original Assignee

Nat Blood Authority

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-10

Filing date

2004-12-26

Publication date

2006-01-15

2004-12-26 Application filed by Nat Blood Authority filed Critical Nat Blood Authority

2006-01-15 Publication of IL165988A0 publication Critical patent/IL165988A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Analytical Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

IL16598804A 2002-07-10 2004-12-26 Process for the preparation of fibrinogen IL165988A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0216001.8A GB0216001D0 (en)	2002-07-10	2002-07-10	Process and composition
PCT/GB2003/002928 WO2004007533A1 (en)	2002-07-10	2003-07-07	Processes for the preparation of fibrinogen

Publications (1)

Publication Number	Publication Date
IL165988A0 true IL165988A0 (en)	2006-01-15

Family

ID=9940203

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16598804A IL165988A0 (en)	2002-07-10	2004-12-26	Process for the preparation of fibrinogen

Country Status (17)

Country	Link
US (1)	US7816495B2 (pl)
EP (1)	EP1519944B1 (pl)
JP (1)	JP4324102B2 (pl)
AT (1)	ATE449104T1 (pl)
AU (1)	AU2003244850B2 (pl)
BR (1)	BRPI0312521B8 (pl)
CA (1)	CA2491716C (pl)
DE (1)	DE60330146D1 (pl)
DK (1)	DK1519944T3 (pl)
EC (1)	ECSP055584A (pl)
ES (1)	ES2332780T3 (pl)
GB (1)	GB0216001D0 (pl)
IL (1)	IL165988A0 (pl)
MX (1)	MXPA05000395A (pl)
NO (1)	NO20050091L (pl)
PL (1)	PL210616B1 (pl)
WO (1)	WO2004007533A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102004009400A1 (de)	2004-02-24	2005-09-08	Zlb Behring Gmbh	Fibrinogen Reinigung
DE102004037805B3 (de) *	2004-08-03	2006-03-23	Zlb Behring Gmbh	Verfahren zur Hitzebehandlung fibrinogenhaltiger pharmazeutischer Zubereitungen
CN101010333B (zh)	2004-08-27	2013-08-14	诺和诺德医疗保健公司	从生物材料中纯化凝血因子xⅲ多肽
ATE540974T1 (de)	2004-11-23	2012-01-15	Zymogenetics Inc	Reinigung des rekombinanten menschlichen faktors xiii
FR2887883B1 (fr)	2005-06-29	2007-08-31	Lab Francais Du Fractionnement	Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
CN101067131B (zh) *	2007-04-30	2011-08-17	华南理工大学	一种利用亲和层析法分离纯化纤溶酶的方法
MX349837B (es)	2008-04-21	2017-08-16	Novo Nordisk Healthcare Ag	Composicion de transglutaminasa seca.
US8945895B2 (en)	2009-07-31	2015-02-03	Baxter International Inc.	Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
CN106046147B (zh)	2010-09-20	2019-11-19	欧克塔医药公司	纤维蛋白原生产方法
AU2013231321B2 (en)	2012-03-13	2017-05-25	Octapharma Ag	Improved process for production of fibrinogen and fibrinogen produced thereby
US9243239B2 (en) *	2012-03-26	2016-01-26	The Regents Of The University Of Colorado, A Body Corporate	Purification of cystathionine beta-synthase
US10188965B2 (en)	2012-12-05	2019-01-29	Csl Behring Gmbh	Hydrophobic charge induction chromatographic depletion of a protein from a solution
US20140154233A1 (en)	2012-12-05	2014-06-05	Csl Limited	Method of purifying therapeutic proteins
US9675678B2 (en)	2013-01-29	2017-06-13	The Regents Of The University Of Colorado, A Body Corporate	Compositions and methods for treatment of homocystinuria
US9932388B2 (en)	2014-11-13	2018-04-03	Hemarus Therapeutics Limited	Chromatographic process for producing high purity fibrinogen and thrombin
PL3998067T3 (pl)	2015-11-09	2025-01-07	The Regents Of The University Of Colorado, A Body Corporate	Kompozycje do leczenia homocystynurii i sposoby jej leczenia
US10695395B2 (en)	2015-12-23	2020-06-30	Phoenix Tissue Repair, Inc.	Collagen 7 compositions and methods of using the same
CA3059592A1 (en)	2017-04-17	2018-10-25	The Regents Of The University Of Colorado, A Body Corporate	Optimization of enzyme replacement therapy for treatment of homocystinuria
SG11202003793WA (en)	2017-10-30	2020-05-28	Baxalta GmbH	Environmentally compatible detergents for inactivation of lipid-enveloped viruses
CN116744986A (zh)	2020-12-25	2023-09-12	广州倍绣生物技术有限公司	纤维蛋白原除菌过滤
CN117794516A (zh)	2021-08-13	2024-03-29	生物测试股份公司	纤维蛋白原组合物和制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2618784B1 (fr)	1987-07-30	1990-04-06	Lille Transfusion Sanguine	Concentre de proteines coagulables par la thrombine, son procede d'obtention et son utilisation a titre de colle biologique
US5445958A (en) *	1987-12-22	1995-08-29	National Blood Authority	Process for purifying blood clotting factors
JPH02193913A (ja)	1989-01-20	1990-07-31	Denki Kagaku Kogyo Kk	パイロジエンを除去する方法
US5169936A (en) *	1989-04-14	1992-12-08	Biogen, Inc.	Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
US5792835A (en) *	1991-09-05	1998-08-11	Baxter International Inc.	Method of preparing a topical fibrinogen complex
AU4693093A (en)	1992-07-27	1994-02-14	Haemacure Biotech Inc.	Biocompatible surgical implant
JPH06138127A (ja)	1992-10-26	1994-05-20	Tanabe Seiyaku Co Ltd	標識フィブリノーゲンおよびその用途
US5395923A (en)	1993-02-23	1995-03-07	Haemacure-Biotech, Inc.	Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
CA2162997A1 (en)	1994-03-18	1995-09-28	Daphne C. Tse	Topical fibrinogen complex
JPH0812586A (ja)	1994-07-01	1996-01-16	Mikimoto Pharmaceut Co Ltd	抗プラスミン剤
GB9424732D0 (en)	1994-12-08	1995-02-08	Common Services Agency	Heat treated blood plasma proteins
JPH08333387A (ja)	1995-06-12	1996-12-17	Mitsubishi Materials Corp	タンパク質分離精製方法
US6268487B1 (en) *	1996-05-13	2001-07-31	Genzyme Transgenics Corporation	Purification of biologically active peptides from milk
GB9722131D0 (en)	1997-10-20	1997-12-17	Medical Res Council	Method
US5981254A (en)	1997-10-30	1999-11-09	Haemacure Corporation	Process for producing thrombin from plasma
AUPP521298A0 (en)	1998-08-12	1998-09-03	Life Therapeutics Limited	Purification of fibrinogen
JP2001270900A (ja)	2000-03-23	2001-10-02	Nihon Pharmaceutical Co Ltd	フィブリノゲンのウイルス不活化法

2002
- 2002-07-10 GB GBGB0216001.8A patent/GB0216001D0/en not_active Ceased
2003
- 2003-07-07 DE DE60330146T patent/DE60330146D1/de not_active Expired - Lifetime
- 2003-07-07 MX MXPA05000395A patent/MXPA05000395A/es active IP Right Grant
- 2003-07-07 US US10/520,436 patent/US7816495B2/en active Active
- 2003-07-07 AU AU2003244850A patent/AU2003244850B2/en not_active Expired
- 2003-07-07 DK DK03738326.2T patent/DK1519944T3/da active
- 2003-07-07 ES ES03738326T patent/ES2332780T3/es not_active Expired - Lifetime
- 2003-07-07 PL PL374080A patent/PL210616B1/pl unknown
- 2003-07-07 EP EP03738326A patent/EP1519944B1/en not_active Expired - Lifetime
- 2003-07-07 AT AT03738326T patent/ATE449104T1/de active
- 2003-07-07 WO PCT/GB2003/002928 patent/WO2004007533A1/en active Application Filing
- 2003-07-07 CA CA2491716A patent/CA2491716C/en not_active Expired - Lifetime
- 2003-07-07 BR BRPI0312521A patent/BRPI0312521B8/pt not_active IP Right Cessation
- 2003-07-07 JP JP2004520819A patent/JP4324102B2/ja not_active Expired - Lifetime
2004
- 2004-12-26 IL IL16598804A patent/IL165988A0/xx unknown
2005
- 2005-01-06 NO NO20050091A patent/NO20050091L/no unknown
- 2005-02-02 EC EC2005005584A patent/ECSP055584A/es unknown

Also Published As

Publication number	Publication date
GB0216001D0 (en)	2002-08-21
DK1519944T3 (da)	2010-03-29
WO2004007533A1 (en)	2004-01-22
PL374080A1 (pl)	2005-09-19
ES2332780T3 (es)	2010-02-12
AU2003244850B2 (en)	2009-06-25
EP1519944B1 (en)	2009-11-18
US20070042944A1 (en)	2007-02-22
BRPI0312521B1 (pt)	2019-06-25
MXPA05000395A (es)	2005-09-30
EP1519944A1 (en)	2005-04-06
DE60330146D1 (de)	2009-12-31
BR0312521A (pt)	2005-04-19
JP4324102B2 (ja)	2009-09-02
CA2491716A1 (en)	2004-01-22
CA2491716C (en)	2012-02-07
US7816495B2 (en)	2010-10-19
NO20050091L (no)	2005-04-06
JP2006505508A (ja)	2006-02-16
AU2003244850A1 (en)	2004-02-02
ATE449104T1 (de)	2009-12-15
PL210616B1 (pl)	2012-02-29
BRPI0312521B8 (pt)	2021-05-25
ECSP055584A (es)	2005-07-06

Publication	Publication Date	Title
IL165988A0 (en)	2006-01-15	Process for the preparation of fibrinogen
TW200508201A (en)	2005-03-01	Novel process for the preparation of roflumilast
TW200510325A (en)	2005-03-16	2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MXPA02004666A (es)	2003-06-24	Gelatinas recombinantes.
MXPA05010682A (es)	2005-12-12	Compuestos novedosos.
MXPA03000627A (es)	2004-07-30	Nuevos peptidos como inhibidores de proteasa serina-ns3 del virus de la hepatitis c.
AU2002220715A1 (en)	2002-06-03	Indolsulfonyl compounds useful in the treatment of cns disorders
MXPA03010134A (es)	2004-03-10	Derivados de ciclohexan-1-4-diamina sustituidos.
TW200519075A (en)	2005-06-16	Novel compounds
GB0111186D0 (en)	2001-06-27	Novel compounds
MXPA04003796A (es)	2004-07-30	Tioacetamidas sustituidas.
PL345215A1 (en)	2001-12-03	Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
IL160171A0 (en)	2004-07-25	Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
PL1668001T3 (pl)	2009-04-30	Podstawione heteroarylobenzofuranowe kwasy
TW200508197A (en)	2005-03-01	Indolone-acetamide derivatives, processes for preparing them and their uses
PL371127A1 (pl)	2005-06-13	Pochodne 6-amino-morfinianu, metody ich otrzymywania oraz ich zastosowania
PT1395546E (pt)	2008-12-30	Processo para a produção de ioexol de elevada pureza
PL374747A1 (pl)	2005-10-31	Sposób wytwarzania preparatu inaktywowanej przez wirus trombiny
GB0320320D0 (en)	2003-10-01	Novel compounds
TW200504402A (en)	2005-02-01	Antimicrobial lenses, processes to prepare them and methods of their use
RS83104A (en)	2006-10-27	Process to prepare eplerenone
TW200517144A (en)	2005-06-01	Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
MXPA04000446A (es)	2004-03-18	4-aminociclohexanoles sustituidos.
MXPA03010498A (es)	2004-05-27	Proceso para la preparacion de imipenem.
MXPA04004090A (es)	2004-07-08	Compuestos substituidos de 1h-quinolin-2-ona.

Legal Events

Date	Code	Title
2013-07-31	KB	Patent renewed
2017-07-31	KB	Patent renewed
2021-07-29	KB	Patent renewed